
BMT Physician @MSKCC | @WeillCornell Graduate School | NK Cell Immunotherapy | Passionate about nature and family
Manhattan, NY
Joined November 2021
- Tweets229
- Following432
- Followers486
- Likes1.3K
One of my favorite things to write with two colleagues from whom I’ve learned a great deal. @MSKCancerCenter
ashpublications.org/blood/ar…
Brian Shaffer retweeted
🚨 BIG NEWS in Cell Therapy! 🚨
New donor selection guidelines—developed with @CIBMTR & partners—are now published in the Journal for Transplantation and Cellular Therapy! 🧬
They reflect the latest in GVHD, expanded donor options & search strategies.
🔗 go.nmdp.org/44CTu8N
Brian Shaffer retweeted
Featured today by @MSKLibrary: Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703 dx.doi.org/10.1200/JCO.24.00…
#BMTCTN1703 #PatientReportedOutcomes #QualityOfLife #TransplantResearch
@sghmd @GvHD_Meade @DrMonzrAlMalki #JuanWu #CarrieLKitko #RanReshef @AndrewRezvan @BrianShafferMD @MelhemSolh @YaoJanny @LRunaas #HanyElmariah #KarilynTLarkin #NajlaElJurdi @MGooptu #AlisonLoren @AricHallMD #AminMAlousi #OmerJamy #WilliamClark @KeanMD @AmiBhattMD #MiguelAngelPerales #KristyApplegate
@YEfebera #EricLeifer #RichardJJones @bmtdata #DeborahMattila @wlsaber @MediHumdani #MichaelJMartens
Brian Shaffer retweeted
Just out in @ASTCT: Updated allogeneic stem cell donor selection guidelines from the CIBMTR/NMDP. Kudos to @mskcancercenter's @BrianShafferMD and team! #stemcelltransplant #Cancer sciencedirect.com/science/ar…
Updated allogeneic stem cell donor guidelines from the CIBMTR/NMDP. A collaborative effort with many wonderful colleagues. Guidelines are adapted for donor selection when using PTCY.
sciencedirect.com/science/ar…
Brian Shaffer retweeted
NEW study results just published in @JCO_ASCO: Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis Following Mismatched Unrelated Donor PBSC Transplantation. Read more: ascopubs.org/doi/10.1200/JCO…
Brian Shaffer retweeted
Amazing to have been part of this endeavour! #donorsforeveryone
@DrStevenDevine @BrianShafferMD @amjimenezmd @DrMonzrAlMalki @JeffAuletta @spellman_s
.@MGooptu, @DanaFarber, and collaborators confirm a new approach to stem cell transplant donor matching that that expands access to safe hematopoietic stem cell transplants across all racial and ethnic backgrounds.
bit.ly/4fDXiKS
San Diego Day 2 for #ASH24 — This is the version you get if you’re from the east coast and you wake up at 3:30 AM.
6
376
Brian Shaffer retweeted
Excited to share our latest perspective on AML MRD in @BMTjournal. Grateful for the opportunity to team up again with @BrianShafferMD, @DrMarcosdelima, and P. Kebriaei. Looking forward to ongoing work with #MRDguru 🙌@DrChrisHourigan!
rdcu.be/d0Sk8
Brian Shaffer retweeted
Here we go! @BrianShafferMD leading us through the morning session addressing controversies re: #PTCy. Dose? Alternatives? Toxicities? @ASTCT #ToxicitiesConference24
For heme/onc fellows that are interested in specialized training in cellular therapy, @MSKCancerCenter offers an advanced fellowship in BMT/Cellular Therapy!
DM me with specific questions, details 👇👇👇I’ll be at #ASH24 if you want to meet.
mskcc.org/hcp-education-trai…
Brian Shaffer retweeted
New CIBMTR Research – the first analysis from @BMTCTN 1702! Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial. Read more, here:
medrxiv.org/content/10.1101/…
Very pleased to share our collaborative work with @MayoClinic @MSKCancerCenter. We used AI to evaluate pre transplant ECG images to predict arrhythmia after #BMT. AI-ECG predicted death after allogeneic HCT.
ashpublications.org/bloodadv…
We believe the use of computer vision on ECGs to predict cancer treatment toxicity is a new paradigm in personalized cancer care, and that this approach may be applicable to other cancer treatments that may be cardiotoxic. More to come!
1
2
199
Brian Shaffer retweeted
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors ➡️ brnw.ch/21wLw9Y @BrianShafferMD @DrStevenDevine #hemonc
Brian Shaffer retweeted
I am once again asking you to consider prescribing olanzapine for patients experiencing chemotherapy-induced nausea/vomiting
* it's an effective antiemetic
* it can enable better sleep (but less daytime somnolence at 2.5mg vs. 10mg)
* it can boost mood
thelancet.com/journals/lanon…
















